You have 9 free searches left this month | for more free features.

daunorubicin

Showing 26 - 50 of 85

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Biospecimen Collection
  • +5 more
  • Buffalo, New York
  • +1 more
Jan 27, 2023

Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Dasatinib, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Innsbruck, Austria
  • +53 more
Sep 19, 2022

Leukemia Trial in New York, Durham, Allentown (drug, other, device)

Active, not recruiting
  • Leukemia
  • Daunorubicin
  • +11 more
  • New York, New York
  • +3 more
Sep 1, 2021

Acute Myeloid Leukemia Trial in United States (Cytarabine, Daunorubicin, Uproleselan)

Suspended
  • Acute Myeloid Leukemia
  • Little Rock, Arkansas
  • +187 more
Aug 17, 2022

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)

Completed
  • Acute Myeloid Leukemia
  • Palo Alto, California
  • +7 more
Aug 6, 2021

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Italy (Cytarabine, Daunorubicin, Midostaurin)

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Bari, Italy
  • +19 more
Mar 1, 2022

Acute Myeloid Leukemia (AML) Trial in France (Idarubicin, Daunorubicin, HD Cytarabine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Amiens, France
  • +54 more
Oct 16, 2020

Acute Myeloid Leukemia Trial in Boston (Alisertib, Cytarabine, Idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
Apr 23, 2020

Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Carfilzomib, Dexamethasone, Mitoxantrone)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • Orange, California
  • +86 more
Nov 14, 2022

Acute Leukemia of Ambiguous Lineage Trial in Tianjin (vincristine, daunorubicin, cyclophosphamide)

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • Tianjin, Tianjin, China
    HBDH
Jun 17, 2020

Acute Lymphobkastic Leukemia Trial in Barcelona (Vincristine, Daunorubicin, Prednisone)

Completed
  • Acute Lymphobkastic Leukemia
  • Barcelona, Spain
    Hospital Germans Trias i Pujol
Mar 3, 2020

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +6 more
  • Duarte, California
  • +25 more
Feb 4, 2022

Newly Diagnosed AML With FLT3 Activating Mutations Trial in United States (crenolanib, cytarabine, daunorubicin)

Completed
  • Newly Diagnosed AML With FLT3 Activating Mutations
  • Duarte, California
  • +8 more
Jul 17, 2020

Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide

Active, not recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Birmingham, Alabama
  • +173 more
Nov 16, 2021

Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)

Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +175 more
Aug 16, 2021

Acute Lymphoblastic Leukemia, Pediatric Trial in Worldwide (Blinatumomab, Bortezomib, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Sydney, Australia
  • +114 more
Nov 1, 2022

Hematologic Malignancy, Acute Myeloid Leukemia Trial in Japan (Entospletinib, Daunorubicin, Cytarabine)

Terminated
  • Hematologic Malignancy
  • Acute Myeloid Leukemia
  • Fukui, Japan
  • +5 more
Feb 21, 2020

Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome Trial in San Francisco (Panobinostat, Cytarabine, Daunorubicin)

Completed
  • Acute Myeloid Leukemia
  • Advanced Myelodysplastic Syndrome
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Apr 19, 2019

Acute Myeloid Leukemia Trial in Tucson, Chicago, Winston-Salem (PF-06747143, Cytarabine, Daunorubicin)

Terminated
  • Acute Myeloid Leukemia
  • PF-06747143
  • +4 more
  • Tucson, Arizona
  • +3 more
Nov 5, 2019

Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood

Active, not recruiting
  • Adult T Acute Lymphoblastic Leukemia
  • +7 more
  • Birmingham, Alabama
  • +211 more
Jan 26, 2022

Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Daunorubicin, Vincristine, PEG-asparaginase)

Completed
  • Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Daunorubicin
  • +9 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 21, 2019

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Worldwide (procedure,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +15 more
  • Birmingham, Alabama
  • +550 more
Jan 28, 2023

Acute Myeloid Leukemia Trial in Canada, Germany, United States (Entospletinib, Daunorubicin, Cytarabine)

Terminated
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +16 more
Nov 13, 2019